Lulus to Report First Quarter 2024 Results on May 8, 2024
CHICO, Calif., April 17, 2024 (GLOBE NEWSWIRE) — Lulu’s Fashion Lounge Holdings, Inc. (“Lulus” or the “Company”) (Nasdaq: LVLU), the […]
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
MOUNTAIN VIEW, Calif., April 17, 2024 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming […]
Cipher Mining Announces Date of First Quarter 2024 Business Update Conference Call
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) — Cipher Mining Inc. (NASDAQ: CIFR) (“Cipher” or the “Company”), a U.S.-based Bitcoin mining company, […]
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting
– Findings from ILLUMINATE Natural History Study show that MRI and fluid biomarkers are emerging as key measures of ALSP […]
Talkspace to Report First Quarter 2024 and Host Conference Call
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) — Talkspace (Nasdaq: TALK), a leading behavioral healthcare company, will release its first […]
Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
SEATTLE, April 17, 2024 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to […]
MDB Capital Holdings Year-End Update
Addison, Texas, April 17, 2024 (GLOBE NEWSWIRE) — MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused […]
Potbelly Corporation Announces Conference Call to Discuss First Quarter 2024 Results on May 8, 2024
CHICAGO, April 17, 2024 (GLOBE NEWSWIRE) — Potbelly Corporation (NASDAQ: PBPB) (“Potbelly” or the “Company”), the iconic neighborhood sandwich shop […]
Remitly to Report First Quarter Financial Results on Wednesday, May 1, 2024
SEATTLE, April 17, 2024 (GLOBE NEWSWIRE) — Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of digital financial services […]
89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
SAN FRANCISCO, April 17, 2024 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development […]
